Clinical trials: Emphysema, Pulmonary

COPD, Chronic Obstructive Pulmonary Disease

Study of COPD Subgroups and Biomarkers

• Active, not recruiting
• Age: 40 to 80 years
• Observational study

SPIROMICS I, SPIROMICS II, and SPIROMICS III are longitudinal observational studies of Chronic Obstructive Pulmonary Disease (COPD) cohort.

Conditions

COPD, Chronic Obstructive Pulmonary Disease, Chronic Bronchitis, Emphysema

Trial name

SPIROMICS (NCT01969344)

Where

14 sites in United States

Volunteers

2,981 people, healthy volunteers welcome

Sponsor

University of North Carolina, Chapel Hill